Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term study.
about
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysisPrevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries.Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide.Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement—a retrospective study
P2860
Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravenous cyclophosphamide p ...... ng disease: a long term study.
@en
Intravenous cyclophosphamide p ...... ng disease: a long term study.
@nl
type
label
Intravenous cyclophosphamide p ...... ng disease: a long term study.
@en
Intravenous cyclophosphamide p ...... ng disease: a long term study.
@nl
prefLabel
Intravenous cyclophosphamide p ...... ng disease: a long term study.
@en
Intravenous cyclophosphamide p ...... ng disease: a long term study.
@nl
P2093
P2860
P1476
Intravenous cyclophosphamide p ...... ng disease: a long term study.
@en
P2093
A Selva-O Callaghan
C P Simeón-Aznar
C Tolosa-Vilella
M Vilardell-Tarrés
R Solans-Laqué
V Fonollosa-Plá
P2860
P356
10.2174/1874306400802010039
P50
P577
2008-05-15T00:00:00Z